[Arterial hypertension in adipose patients. Rationale for a prospective medical care study in the family physician practice].
Bramlage
P
P
Institut für Klinische Pharmakologie, Medizinische Fakultät der TU, Fiedlerstr 27, D-01307 Dresden.
Sharma
A M
AM
Kirch
W
W
D000293:Adolescent; D000328:Adult; D000368:Aged; D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001713:Biphenyl Compounds / Q000627:therapeutic use*; D015992:Body Mass Index; D002986:Clinical Trials as Topic; D015897:Comorbidity; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000453:epidemiology; D000077405:Irbesartan; D008875:Middle Aged; D009765:Obesity / Q000150:complications* / Q000453:epidemiology; D011446:Prospective Studies; D013777:Tetrazoles / Q000627:therapeutic use*; D016896:Treatment Outcome
D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents; D001713:Biphenyl Compounds; D013777:Tetrazoles; D000077405:Irbesartan